Myomo (MYO) Gross Profit Growth (1y) (2017 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Profit Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 6.52% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 1.76% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 4.41% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 12.59% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 15.74% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 6.30% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 27.39% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -1.74% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 8.72% |
| 10 | Myomo | 44.63 Mn | 26.23 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -7.25% |
| Jun 30, 2025 | 13.64% |
| Mar 31, 2025 | 187.49% |
| Dec 31, 2024 | 177.47% |
| Sep 30, 2024 | 99.08% |
| Jun 30, 2024 | 24.40% |
| Mar 31, 2024 | -0.37% |
| Dec 31, 2023 | 18.16% |
| Sep 30, 2023 | 32.30% |
| Jun 30, 2023 | 78.29% |
| Mar 31, 2023 | -10.46% |
| Dec 31, 2022 | -15.85% |
| Sep 30, 2022 | -19.45% |
| Jun 30, 2022 | 9.01% |
| Mar 31, 2022 | 50.42% |
| Dec 31, 2021 | 12.22% |
| Sep 30, 2021 | 205.58% |
| Jun 30, 2021 | 400.93% |
| Mar 31, 2021 | 148.49% |
| Dec 31, 2020 | 153.86% |
| Sep 30, 2020 | 286.21% |
| Jun 30, 2020 | -12.10% |
| Mar 31, 2020 | 26.92% |
| Dec 31, 2019 | 65.22% |
| Sep 30, 2019 | -33.22% |
| Jun 30, 2019 | 15.82% |
| Mar 31, 2019 | 164.88% |
| Dec 31, 2018 | 93.16% |
| Sep 30, 2018 | 13.98% |
| Jun 30, 2018 | 107.61% |
| Mar 31, 2018 | 48.99% |
| Dec 31, 2017 | -2.50% |
| Sep 30, 2017 | 240.24% |
| Jun 30, 2017 | 2.04% |